Global Atrial Fibrillation Drugs Market Industry Insight, Revenue Analysis and Forecast to 2027

The market for oral atrial fibrillation medication delivery was estimated to be valued USD 10,403,0 million in 2021. The prevalence of atrial fibrillation is rapidly increasing over the world, particularly as the population ages. Compared to other types of stroke, thromboembolic stroke brought on by atrial fibrillation is linked to higher morbidity, mortality, and lengthier hospital stays. Due to their effectiveness in avoiding blood clotting and ability to accelerate market expansion, oral pharmaceutical therapies are the most frequently suggested drug therapy for the prevention of atrial strokes.